RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response (Q44985080)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

8 December 2017

RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response (English)

1 reference

Europe PubMed Central

8 December 2017

0 references

1 reference

based on heuristic

inferred from title

ovarian carcinoma

1 reference

based on heuristic

inferred from title

author name string

Verena Materna

1

1 reference

Europe PubMed Central

8 December 2017

Juliane Pleger

2

1 reference

Europe PubMed Central

8 December 2017

Uwe Hoffmann

3

1 reference

Europe PubMed Central

8 December 2017

Hermann Lage

4

1 reference

Europe PubMed Central

8 December 2017

language of work or name

0 references

publication date

1 July 2004

1 reference

Europe PubMed Central

8 December 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

8 December 2017

94

1 reference

Europe PubMed Central

8 December 2017

1

1 reference

Europe PubMed Central

8 December 2017

152-160

1 reference

Europe PubMed Central

8 December 2017

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Multidrug resistance (mdr) genes in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

ABC-transporters: implications on drug resistance from microorganisms to human cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

P-glycoprotein: from genomics to mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

The MRP family of drug efflux pumps

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Overexpression of cMOAT (MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Cellular roles of dna topoisomerases: a molecular perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Clinical applications of the camptothecins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Topoisomerase I and II activity in human breast, cervix, lung and colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Elevations of DNA topoisomerase I in invasive carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Competitive PCR

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Validation and clinical implication of a quantitative real-time PCR determination of MDR1 gene expression: comparison with semi-quantitative PCR in 101 patients with acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Quantification of bacterial transcripts during infection using competitive reverse transcription-PCR (RT-PCR) and LightCycler RT-PCR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Comparison and verification of quantitative competitive reverse transcription polymerase chain reaction (QC-RT-PCR) and real time RT-PCR for avian leukosis virus subgroup J.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Quantitative reverse transcription-polymerase chain reaction (RT-PCR): a comparison of primer-dropping, competitive, and real-time RT-PCRs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Expression of genes of potential importance in the response to chemotherapy and DNA repair in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Expression of P-glycoprotein in epithelial ovarian cancer: evaluation as a marker of multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Multiple drug resistance parameter expression in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Variation in topoisomerase I gene copy number as a mechanism for intrinsic drug sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Gene expression of DNA topoisomerases I, II alpha and II beta and response to cisplatin-based chemotherapy in advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Immunohistochemical detection of DNA topoisomerase I in formalin fixed, paraffin wax embedded normal tissues and in ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

DNA-topoisomerase I activity and content in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.03.035

7 January 2021

Identifiers

10.1016/J.YGYNO.2004.03.035

1 reference

Europe PubMed Central

8 December 2017

1 reference

Europe PubMed Central

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44985080&oldid=2060440237"